Clinical Trials Browser

Active not recruiting × Breast Neoplasms × PVX-410 vaccine × Clear all

NCT03362060 2025-10-01

PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms